RJFSA
ONCE

Raymond James Financial Services Advisors’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Raymond James Financial Services Advisors’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2,105
Closed -$204K – 2998
2019
Q3 		$204K Sell
2,105
-38
-2% -$3.81K ﹤0.01% 2497
2019
Q2 		$219K Sell
2,143
-937
-30% -$101K ﹤0.01% 2477
2019
Q1 		$351K Buy
+3,080
New +$226K ﹤0.01% 2137

Raymond James Financial Services Advisors's ONCE Position: Q4 2019 in Review

Raymond James Financial Services Advisors sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 2,105 shares — an estimated $204K sold.

Raymond James Financial Services Advisors first reported a position in ONCE in Q1 2019 and held it in 3 quarters. The position peaked at $351K in Q1 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

  • Raymond James Financial Services Advisors reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 2,105 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $204K.
  • Raymond James Financial Services Advisors first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2019 and held it in 3 quarters.
  • Raymond James Financial Services Advisors's Spark Therapeutics, Inc. Common Stock position peaked at $351K in Q1 2019.
  • 0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Raymond James Financial Services Advisors's 13F filing for Q4 2019, filed 12 Feb 2020.